Long COVID
226
52
78
88
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
15 trials with published results (7%)
Research Maturity
88 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.9%
2 terminated out of 226 trials
97.8%
+11.3% vs benchmark
4%
8 trials in Phase 3/4
17%
15 of 88 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 88 completed trials
Clinical Trials (226)
Long COVID Brain Fog: Cognitive Rehabilitation Trial
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Living With Long COVID: LONGCOVID-EXPERIENCE
Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Improving Attention in Individuals With Long COVID-19
Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Is Swimming a More Tolerable Form of Movement for Individuals With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome?
RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Understanding the Long-term Impact of COVID-19 in Adults
A Study to Assess Anktiva in Patients With Long Covid-19.
Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition
DAOIB for the Treatment of Brain Fog
Taurine Supplementation in Long COVID
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Antiviral Clinical Trial for Long Covid-19
Characterization of the Immunometabolic Signature in Long COVID-19.